Here's the live share price of Solara Active Pharma Sciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Solara Active Pharma Sciences has declined 6.00% CAGR. Over the past year, the corresponding return has been -11.76%.
Solara Active Pharma Sciences’s current P/E of 121.20x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Solara Active Pharma Sciences | -1.14 | 6.18 | 25.96 | 32.27 | -11.70 | 19.10 | -5.98 |
Sun Pharmaceutical Industries | 1.92 | 0.78 | -1.00 | -5.87 | -11.69 | 21.62 | 26.75 |
Divi's Laboratories | 1.95 | 2.32 | -6.76 | 5.50 | 12.73 | 19.13 | 14.23 |
Cipla | -0.94 | 0.85 | 3.90 | 3.04 | -4.91 | 12.62 | 15.22 |
Torrent Pharmaceuticals | 1.88 | -0.81 | 14.66 | 12.49 | 4.95 | 33.95 | 21.86 |
Dr. Reddy's Laboratories | -0.18 | 5.50 | -0.86 | 10.74 | 0.27 | 15.93 | 5.04 |
Mankind Pharma | 1.11 | 4.10 | 13.95 | 16.14 | 2.40 | 22.35 | 12.87 |
Zydus Lifesciences | -0.42 | 5.84 | 8.73 | 13.50 | -1.41 | 41.05 | 21.31 |
Lupin | -0.78 | 4.45 | 4.11 | -2.78 | -5.83 | 44.53 | 14.26 |
Alkem Laboratories | 1.10 | 2.06 | 15.28 | 12.32 | -9.54 | 18.40 | 13.96 |
Abbott India | -1.00 | -6.02 | -2.77 | 1.57 | 8.64 | 19.16 | 14.04 |
Aurobindo Pharma | 2.31 | 7.07 | 2.16 | -4.64 | -25.18 | 28.04 | 7.20 |
Glenmark Pharmaceuticals | -3.83 | 6.56 | 25.18 | 38.63 | 26.07 | 75.08 | 34.06 |
Laurus Labs | 2.33 | 4.68 | 40.77 | 51.72 | 96.17 | 20.22 | 26.29 |
Biocon | -0.25 | 1.35 | 3.58 | 6.80 | -0.38 | 6.88 | -3.22 |
Anthem Biosciences | 0.68 | -0.24 | 14.88 | 14.88 | 14.88 | 4.73 | 2.81 |
GlaxoSmithKline Pharmaceuticals | 0 | -0.38 | -13.42 | -3.00 | 2.36 | 25.61 | 10.37 |
Ipca Laboratories | 6.17 | 1.97 | 1.69 | -0.33 | -2.64 | 17.02 | 6.03 |
Cohance Lifesciences | -8.99 | -0.06 | -9.35 | -25.19 | -26.46 | 24.58 | 18.72 |
Gland Pharma | -0.85 | 3.08 | 16.38 | 26.04 | 11.58 | -3.46 | 1.94 |
Over the last one year, Solara Active Pharma Sciences has declined 11.70% compared to peers like Sun Pharmaceutical Industries (-11.69%), Divi's Laboratories (12.73%), Cipla (-4.91%). From a 5 year perspective, Solara Active Pharma Sciences has underperformed peers relative to Sun Pharmaceutical Industries (26.75%) and Divi's Laboratories (14.23%).
Day | SMA | EMA |
---|---|---|
5 | 678.8 | 678.23 |
10 | 676.8 | 673.18 |
20 | 656.56 | 661.45 |
50 | 646.42 | 637.23 |
100 | 587.11 | 611.85 |
200 | 584.73 | 595.93 |
In the latest quarter, Solara Active Pharma Sciences saw a drop in promoter holding to 42.00%, while DII stake increased to 2.62%, FII holding fell to 14.25%, and public shareholding moved down to 41.10% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Aditya Birla Sun Life Flexi Cap Fund | 4,20,000 | 0.11 | 25.74 |
Aditya Birla Sun Life Manufacturing Equity Fund | 1,46,107 | 0.86 | 8.96 |
Motilal Oswal BSE Healthcare ETF | 749 | 0.14 | 0.05 |
Date Time | Announcement |
---|---|
Sep 03, 2025, 3:00 AM IST | Solara Active Pharma - Business Responsibility and Sustainability Reporting (BRSR) |
Sep 03, 2025, 2:54 AM IST | Solara Active Pharma - Reg. 34 (1) Annual Report. |
Sep 03, 2025, 2:36 AM IST | Solara Active Pharma - Notice Of The 8Th Annual General Meeting |
Aug 22, 2025, 12:35 AM IST | Solara Active Pharma - Intimation Regarding 100 Days Campaign - Saksham Niveshak |
Aug 16, 2025, 6:35 PM IST | Solara Active Pharma - Receipt Of Call Money Pursuant To The First Reminder Notice Issued For Payment Of First Call Money On |
Solara Active Pharma Sciences Ltd. is a Public Limited Listed company incorporated on 23/02/2017 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH2017PLC291636 and registration number is 291636. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 1283.76 Cr. and Equity Capital is Rs. 40.25 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Solara Active Pharma Sciences is ₹668.90 as on Sep 22, 2025.
The Solara Active Pharma Sciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Solara Active Pharma Sciences is ₹2,971.29 Cr as on Sep 22, 2025.
Today’s highest and lowest price of Solara Active Pharma Sciences are ₹676.35 and ₹665.05.
The 52-week high/low is the highest and lowest price at which Solara Active Pharma Sciences stock has traded in the past 52-week or nearly a year. The 52-week high of Solara Active Pharma Sciences is ₹885.95 and 52-week low of Solara Active Pharma Sciences is ₹441.10 as on Sep 22, 2025.
The Solara Active Pharma Sciences has shown returns of -1.23% over the past day, 6.11% for the past month, 25.87% over 3 months, -11.76% over 1 year, 19.07% across 3 years, and -6.0% over 5 years.
P/E ratio of and PB ratio of Solara Active Pharma Sciences are 121.20 and 2.72 on Sep 22, 2025. While the company gives a dividend yield of 0.00 per annum.